Dendritic cells in precancerous lesions of the larynx

Laryngoscope

Volumn 110, Issue 1, 2000, Pages 13-18

  Sprinzl, Georg Mathias ^a   Hussl, Burkhard ^a   Obrist, Peter ^a   Yoneda, Kozo ^c   Thumfart, Walter Franz ^a   Romani, Nikolaus ^b   Schrott Fischer, Annelies ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Dendritic cells; Langerhans' cells; Larynx; Precancerous lesions

Indexed keywords

CD20 ANTIGEN; CELL SURFACE MARKER; HLA DR ANTIGEN; PROTEIN S 100;

ADULT; AGED; ANTIBODY LABELING; ARTICLE; CANCER GRADING; CELL DENSITY; CELL INFILTRATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DYSPLASIA; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LANGERHANS CELL; LARYNX CANCER; LARYNX MUCOSA; MALE; MEMORY CELL; PRECANCER; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

EID: 0033958816     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200001000-00003     Document Type: Article

References (36)

1. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-252.
2. Romani N, Kampgen E, Koch F, Heufler C, Schuler G. Dendritic cell production of cytokines and responses to cytokines. Int Rev Immunol 1990;6:151-161.
3. Pavli P, Maxwell L, Van-de-Pol E, Doe F. Distribution of human colonic dendritic cells and macrophages. Clin Exp Immunol 1996;104:124-132.
4. McWilliam AS, Nelson DJ, Holt PG. The biology of airway dendritic cells. Immunol Cell Biol 1995;73:405-413
5. Hussl B, Egg G, Romani N, Kong W, Schrott-Fischer A. Dendritic cells in the normal human tympanic membrane. Ann Otol Rhinol Laryngol 1995;104:803-807.
6. Horst HA, Horny HP. Tumor-infiltrating lymphoreticular cells: histologic and immunohistologic investigations performed on metastasizing squamous cell carcinomas of the head and neck. Cancer 1991;68:2397-2402
7. Garrity T, Pandit R, Wright MA, Benefield J, Keni S, Young MR. Increased presence of CD34+ cells in the peripheral blood of head and neck cancer patients and their differentiation into dendritic cells. Int J Cancer 1997;73:663-669.
8. Schuler G, Steinman RM. Dendritic cells as adjuvants for immune-mediated resistance to tumors. J Exp Med 1997; 186:1183-1187.
9. Shurin MR. Dendritic cells presenting tumor antigen. Cancer Immunol Immunother 1996;43:158-164.
10. Nestle FO, Alijagic S, Gilliet M, et al. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells [see comments]. Nat Med 1998;4:328-332.
11. Jecker P, Ptok M, Pabst R, Westermann J. Age dependency of the composition of immunocompetent cells and the expression of adhesion molecules in rat laryngeal mucosa. Laryngoscope 1996;106:733-738.
12. Gallo O, Bianchi S, Giannini A, Gallina E, Libonati GA, Fini-Storchi O. Correlations between histopathological and biological findings in nasopharyngeal carcinoma and its prognostic significance. Laryngoscope 1991;101:487-493.
13. Goldman SA, Baker E, Weyant RJ, Clarke MR, Myers JN, Lotze MT. Peritumoral CD1a-positive dendritic cells are associated with improved survival in patients with tongue carcinoma. Arch Otolaryngol Head Neck Surg 1998;124: 641-646.
14. Girod SC, Kuhnast T, Ulrich S, Krueger GR. Langerhans cells in epithelial tumors and benign lesions of the oropharynx. In Vivo 1994;8:543-547.
15. Zeid NA, Muller HK. S100 positive dendritic cells in human lung tumors associated with cell differentiation and enhanced survival. Pathology 1993;25:338-343.
16. Furihata M, Ohtsuki Y, Ido E, et al. HLA-DR antigen- and S-100 protein-positive dendritic cells in esophageal squamous cell carcinoma: their distribution in relation to prognosis. Virchows Arch 1992;61:409-414.
17. Gallo O, Libonati GA, Gallina E, et al. Langerhans cells related to prognosis in patients with laryngeal carcinoma. Arch Otolaryngol Head Neck Surg 1991;117:1007-1010.
18. Lotze MT, Jaffe R. Cancer. In: Lotze MT, Thomson AW, eds. Dendritic Cells: Biology and Clinical Applications. San Diego, CA: Academic Press, 1999:325-338.
19. Kleinsasser O. Microlaryngoscopy and Endolaryngeal Microsurgery, edn 3. London: Mosby-Year Book, 1992:63-69.
20. Kashihara M, Ueda M, Horiguchi Y, Furukawa F, Hanaoka M, Imamura S. A monoclonal antibody specifically reactive to human Langerhans cells. J Invest Dermatol 1986;87: 602-607.
21. Celluzzi CM, Mayordomo JI, Storkus WJ, Lotze MT, Falo-LD J. Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity [see comments]. J Exp Med 1996;183:283-287.
22. Specht JM, Wang G, Do MT, et al. Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases. J Exp Med 1997;186:1213-1221.
23. Zitvogel L, Mayordomo JI, Tjandrawan T, et al. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells B7 costimulation and T helper cell 1-associated cytokines [see comments]. J Exp Med 1996; 183:87-97.
24. Rosenberg SA, Yang JC, Schwartzentruber DJ, et al. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma [see comments]. Nat Med 1998;4:321-327.
25. Stingl G, Bröcker EB, Mertelsmann R, et al. Phase I study to the immunotherapy of metastatic malignant melanoma by a cancer vaccine consisting of autologous cancer cells transfected with the human IL-2 gene. Hum Gene Ther 1996;7:551-563.
26. Höltl L, Rieser C, Papesh C, et al. Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells. J Urol 1999;161:777-782.
27. Dummer W, Bastian BC, Ernst N, Schanzle C, Schwaaf A, Bröcker EB. Interleukin-10 production in malignant melanoma: preferential detection of IL-10-secreting tumor cells in metastatic lesions. Int J Cancer 1996;66:607-610.
28. Enk AH, Jonuleit H, Saloga J, Knop J. Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma. Int J Cancer 1997;73:309-316.
29. Saito H, Tsujitani S, Ikeguchi M, Maeta M, Kaibara N. Relationship between the expression of vascular endothelial growth factor and the density of dendritic cells in gastric adenocarcinoma tissue. Br J Cancer 1998;78:1573-1577.
30. Cumberbatch M, Dearman RJ, Kimber I. Langerhans cells require signals from both tumour necrosis factor-alpha and interleukin-1 beta for migration. Immunology 1997;92: 388-395.
31. Fichelson S. The FLT3/FLK2 ligand: structure functions and prospects. Eur Cytokine Netw 1998;9:7-22.
32. Lynch DH, Andreasen A, Maraskovsky E, Whitmore J, Miller RE, Schuh JC. Flt3 ligand induces tumor regression and antitumor immune responses in vivo. Nat Med 1997;3: 625-631.
33. Peron JM, Esche C, Subbotin VM, Maliszewski C, Lotze MT, Shurin MR. FLT3-ligand administration inhibits liver metastases: role of NK cells. J Immunol 1998;161:6164-6170.
34. Schuler G, Thurner B, Romani N. Dendritic cells: from ignored cells to major players in T-cell-mediated immunity. Int Arch Allergy Immunol 1997;112:317-322.
35. Romani N, Reider D, Heuer M, et al. Generation of mature dendritic cells from human blood: an improved method with special regard to clinical applicability. J Immunol Methods 1996;196:137-151.
36. Thurner B, Röder C, Dieckmann D, et al. Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application. J Immunol Methods 1999;223:1-15.